South Carolina § 44-53-1830 Cannabidiol for use in clinical trials.

South Carolina Statutes

§ 44-53-1830 — Cannabidiol for use in clinical trials.

South Carolina § 44-53-1830

Title 44HEALTH

Ch. 53POISONS, DRUGS, AND OTHER CONTROLLED SUBSTANCES

This text of South Carolina § 44-53-1830 (Cannabidiol for use in clinical trials.) is published on Counsel Stack Legal Research, covering South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.C. Code Ann. § 44-53-1830 (2026).

Text

(A)Expanded access clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to this chapter only shall utilize cannabidiol which is:

(1)from an approved source; and (2) approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application.

(B)The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the expanded access clinical trials.

Free access — add to your briefcase to read the full text and ask questions with AI

(A) Expanded access clinical trials conducted pursuant to a statewide investigational new drug application established pursuant to this chapter only shall utilize cannabidiol which is: (1) from an approved source; and (2) approved by the United States Food and Drug Administration to be used for treatment of a condition specified in an investigational new drug application. (B) The principal investigator and any subinvestigator may receive cannabidiol directly from an approved source or authorized distributor for an approved source for use in the expanded access clinical trials.